Gout: Introduction FeedbackA general introduction to Gout.Source: Clinical Knowledge Summaries, 01 Aug 2012
Gout is a disorder of purine metabolism characterized by a raised uric acid level in the blood (hyperuricaemia) and the deposition of urate crystals in joints and other tissues.
The natural history of gout can occur in three distinct phases:
A long period of asymptomatic hyperuricaemia.
A period during which acute attacks of gouty arthritis are followed by variable intervals (months to years) when there are no symptoms.
The final period of chronic tophaceous gout where people have nodules affecting joints.
Hyperuricaemia is the single most important risk factor for developing gout.
Gout is more common in men and in older people. Only 3–6% of people with gout have onset of the disease before 25 years of age.
Hyperuricaemia-induced renal disease is a possible complication of gout. Also, tophi may become inflamed, exude tophaceous material, or develop secondary infection.
First acute attacks of gout usually completely subside in 3–10 days. However, attacks may recur.
The diagnosis of gout is based on the clinical history and examination. There is no single examination which confirms a diagnosis of gout.
To manage an acute attack of gout:
A nonsteroidal anti-inflammatory drug (NSAID) e.g. diclofenac, should be prescribed as soon as possible and continued until 48 hours after the attack has resolved (a proton pump inhibitor or misoprostol can be co-prescribed for gastric protection, if necessary).
If NSAIDs are unsuitable, colchicine is an option.
If colchicine is unsuitable, systemic corticosteroids can be considered.
Paracetamol (with or without codeine) should be used if NSAIDs, colchicine, and corticosteroids are all unsuitable.
Appropriate self-care advice should be given (e.g. rest and keeping the joint in a cool environment by avoiding clothing and using an ice pack).
Appropriate life-style advice should be provided (e.g. weight loss and smoking cessation).
If there is no improvement in symptoms after 2–3 days:
The diagnosis should be reviewed.
Compliance with medications and self-care strategies should be checked.
Medication can be increased to the maximum dose.
To prevent an attack of gout:
Allopurinol should be prescribed — after two or more attacks of gout within a year or after the first attack in people at higher risk with one or more tophi, X-ray features of gouty arthritis, renal impairment, known uric acid stones, or on long-term diuretic medication.
Febuxostat can be considered as second-line therapy if allopurinol is not tolerated or contraindicated.
Co-prescription of a low dose of an NSAID or low-dose colchicine may prevent acute attacks of gout during urate lowering treatment with allopurinol or febuxostat.
Allopurinol or febuxostat should be started 1-2 weeks after the inflammation has settled, as the drug may precipitate further attacks.
Advice should be sought from a specialist if:
The diagnosis is uncertain.
Gout occurs during pregnancy or in a person under 25 years of age.
Complications are present.
The person is at risk of adverse effects of drug treatment.
Gout: Guidance FeedbackThe most relevant search results for Gout from producers of guidance information.
Information for the public
Gout: Information for the public FeedbackThe most relevant search results for Gout, from Department of Health accredited producers of patient information.
- Bupa , 16 January 2014
- NHS Choices, 20 March 2012
TA291 Gout (tophaceous, severe debilitating, chronic) - pegloticase: information for the public [PDF]National Institute for Health and Care Excellence, 26 June 2013
- Patient UK
- Patient UK
- NHS Choices, 09 May 2013
Gout: Ongoing Research FeedbackThe most relevant search results for Gout, from research trials.
Gout: Evidence Uncertainty FeedbackThe most relevant search results for Gout, highlighting areas where further research is needed.
- UK Database of Uncertainties about the Effects of Treatments, 03 June 2013
- UK Database of Uncertainties about the Effects of Treatments, 02 May 2013
- UK Database of Uncertainties about the Effects of Treatments, 09 December 2013
- UK Database of Uncertainties about the Effects of Treatments, 16 November 2012
- UK Database of Uncertainties about the Effects of Treatments, 20 November 2012
- UK Database of Uncertainties about the Effects of Treatments, 02 May 2013
- UK Database of Uncertainties about the Effects of Treatments, 18 January 2010
- UK Database of Uncertainties about the Effects of Treatments, 24 September 2012
- UK Database of Uncertainties about the Effects of Treatments, 20 July 2012
- UK Database of Uncertainties about the Effects of Treatments, 23 October 2012
Gout: Medicines FeedbackAppropriate medicines information for Gout supplied by Datapharm, a leading source of trusted, credible information about medicines.
Gout - Medicines Information
- Adenuric (a brand of Febuxostat)
- Diclofenac potassium
- Diclofenac sodium
- Dicloflex (a brand of Diclofenac Sodium)
- Diclomax (a brand of Diclofenac Sodium)
- Econac (a brand of Diclofenac Sodium)
- Etoricoxib (a generic version of Arcoxia)
- Ketocid (a brand of Ketoprofen)
- Ketovail (a brand of Ketoprofen)
- Motifene (a brand of Diclofenac Sodium)
- Orudis (a brand of Ketoprofen)
- Oruvail (a brand of Ketoprofen)
- Voltarol (a brand of Diclofenac Sodium)
- Voltarol Dispersible (a brand of Diclofenac Sodium)
- Voltarol Rapid (a brand of Diclofenac Potassium)
- Zyloric (a brand of Allopurinol)
- Results are currently sorted by relevance (Sort results by: date)
- Results 1 - 10 (of 14)
...bone. Crystal deposition — principally gout or, rarely, pseudogout. Systemic disease...on Baker's cyst, Cellulitis - acute, Gout, Greater trochanteric pain syndrome... Crystal deposition — principally gout or, rarely, pseudogout [Wasserman et...
Clinical Knowledge Summaries, 01 November 2010
...Managing any associated conditions, such as gout, cellulitis, or rheumatoid arthritis...sites. There are separate CKS topics on Gout, Greater trochanteric pain syndrome... Systemic conditions — most commonly gout or rheumatoid arthritis (intra-bursal...
Clinical Knowledge Summaries, 11 October 2010
...rheumatoid arthritis, osteoarthritis and gout.9, 63-66 1++ 1++ 1...Rheumatology guideline for the management of gout. Rheumatology 2007;46(8):1372...EULAR evidence based recommendations for gout. Part II: Management. Report of a task...
Scottish Intercollegiate Guidelines Network, 06 December 2013
...Necrotizing fasciitis. Gangrene. Acute gout. Adverse drug reactions. Metastatic...topic on Deep vein thrombosis. Acute gout — swelling, redness, warmth, and pain...skin around the joint may be inflamed (gout cellulitis). For more information see...
Clinical Knowledge Summaries, 01 September 2012
...diuretics are best avoided in people with gout, as they may cause hyperuricaemia (increased serum uric acid levels) and gout. If a thiazide-type diuretic is necessary...with allopurinol. See the CKS topic on Gout. Adverse effects What are the...
Clinical Knowledge Summaries, 01 July 2010
...between protocol and review Index terms Description of the condition Neuropathic pain, unlike nociceptive pain such as gout and other forms of arthritis, is caused by nerve damage, often accompanied by changes in the central nervous system (CNS...
Cochrane Database of Systematic Reviews, 12 December 2012 - Publisher: John Wiley & Sons, Ltd
...unlike nociceptive pain (pain that arises from nerve endings detecting unpleasant or painful stimuli), such as arthritis, or gout, is caused by nerve damage, often accompanied by changes in the central nervous system. There have been several changes...
Cochrane Database of Systematic Reviews, 16 March 2011 - Publisher: John Wiley & Sons, Ltd
...calculation: if glucose is low, this may indicate lactic acidaemia. Urate: there may be high urate levels and even associated gout. Renal function tests. Creatine kinase. FBC: there may be anaemia, neutropenia. Coagulation studies: increased...
Patient UK, 28 September 2011
Flucloxacillin 250 mg, 500mg,1g Powder for Solution for Injection or Infusion (Bowmed Limited) - X-PIL
...an antibiotic You are being treated for kidney problems or gout You are being treated for liver problems You are on a low sodium...Flucloxacillin injection are: Probenecid (used for the treatment of gout) Oral contraceptives that contain oestrogen (the “pill...
electronic Medicines Compendium, 15 July 2013 - Publisher: X-PIL, Datapharm Communications Ltd - Publication type: Alternative format Patient Information Leaflet
...before taking this medicine if you are taking any other medicines, especially: Probenecid or sulfinpyrazone (used to treat gout) Methotrexate (a chemotherapy drug) The contraceptive pill as antibiotics can make these less effective (you will need...
electronic Medicines Compendium, 01 February 2012 - Publisher: X-PIL, Datapharm Communications Ltd - Publication type: Alternative format Patient Information Leaflet
Searches related to “Gout”
- Areas of interest
- Types of information
Start typing a Source name to narrow your search, or select one or more from the A-Z list
Medicines and devices
Start typing a Medicine or device name to narrow your search, or select one or more from the A-Z list
- Certolizumab pegol(4)
- Diclofenac potassium(6)
- Diclofenac sodium(9)
- Glucosamine hydrochloride(1)
- Glucosamine sulfate(1)
- Insulin glargine(1)
- Interferon alfa-2a(4)
- Interferon alfa-2b(6)
- Interferon beta-1a(1)
- Irbesartan + hydrochlorothiazide(4)
- Iron sucrose(2)
- Mefenamic acid(2)
- Mycophenolate mofetil(21)
- Naproxen + esomeprazole(1)
- Nicotinic acid(2)
- Peginterferon alfa-2a(6)
- Peginterferon alfa-2b(7)
- Strontium ranelate(4)
- Tenofovir + emtricitabine(2)
- Valsartan + hydrochlorothiazide(7)
- Clear all filters